Sharifi A, Moeini A, Nabi-Afjadi M
Clin Diabetes Endocrinol. 2024; 10(1):44.
PMID: 39658786
PMC: 11633081.
DOI: 10.1186/s40842-024-00195-4.
Ghenciu L, Hategan O, Bolintineanu S, Danila A, Faur A, Prodan-Barbulescu C
Biomedicines. 2024; 12(6).
PMID: 38927510
PMC: 11201425.
DOI: 10.3390/biomedicines12061303.
Ladea L, Zemba M, Calancea M, Caltaru M, Dragosloveanu C, Coroleuca R
Int J Mol Sci. 2024; 25(6).
PMID: 38542443
PMC: 10970528.
DOI: 10.3390/ijms25063471.
Rozema J, Khan A, Atchison D
Adv Ophthalmol Pract Res. 2023; 2(2):100048.
PMID: 37846385
PMC: 10577873.
DOI: 10.1016/j.aopr.2022.100048.
Ciorba A, Roiu G, Abdelhamid A, Saber S, Cavalu S
Diagnostics (Basel). 2023; 13(6).
PMID: 36980422
PMC: 10047116.
DOI: 10.3390/diagnostics13061115.
Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers.
Ferrara M, Loda A, Coco G, Grassi P, Cestaro S, Rezzola S
J Clin Med. 2023; 12(3).
PMID: 36769560
PMC: 9917666.
DOI: 10.3390/jcm12030912.
Mechanistic investigations of diabetic ocular surface diseases.
Zhou Q, Yang L, Wang Q, Li Y, Wei C, Xie L
Front Endocrinol (Lausanne). 2023; 13:1079541.
PMID: 36589805
PMC: 9800783.
DOI: 10.3389/fendo.2022.1079541.
Keeping an eye on the diabetic foot: The connection between diabetic eye disease and wound healing in the lower extremity.
Ramsey D, Kwan J, Sharma A
World J Diabetes. 2022; 13(12):1035-1048.
PMID: 36578874
PMC: 9791566.
DOI: 10.4239/wjd.v13.i12.1035.
The Effect of Fluorosecein on Corneal Endothelial Structure and Morphology in Diabetic Retinopathy Patients undergone Fundus Fluoresecein Angiography.
Calli U, Ozturk Y, Demir G
Beyoglu Eye J. 2022; 7(1):35-38.
PMID: 35265800
PMC: 8874254.
DOI: 10.14744/bej.2021.80664.
Potential underlying genetic associations between keratoconus and diabetes mellitus.
Ates K, Estes A, Liu Y
Adv Ophthalmol Pract Res. 2021; 1.
PMID: 34746916
PMC: 8570550.
DOI: 10.1016/j.aopr.2021.100005.
The effect of diabetes on corneal endothelium: a meta-analysis.
Zhang K, Zhao L, Zhu C, Nan W, Ding X, Dong Y
BMC Ophthalmol. 2021; 21(1):78.
PMID: 33568093
PMC: 7874671.
DOI: 10.1186/s12886-020-01785-3.
The relationship of central corneal thickness with the status of diabetic retinopathy.
Canan H, Sahinoglu-Keskek N, Altan-Yaycioglu R
BMC Ophthalmol. 2020; 20(1):220.
PMID: 32513125
PMC: 7278140.
DOI: 10.1186/s12886-020-01411-2.
Diabetic keratopathy: Insights and challenges.
Priyadarsini S, Whelchel A, Nicholas S, Sharif R, Riaz K, Karamichos D
Surv Ophthalmol. 2020; 65(5):513-529.
PMID: 32092364
PMC: 8116932.
DOI: 10.1016/j.survophthal.2020.02.005.
Corneal endothelial cell changes in diabetics versus age group matched nondiabetics after manual small incision cataract surgery.
Kudva A, Lasrado A, Hegde S, Kadri R, Devika P, Shetty A
Indian J Ophthalmol. 2019; 68(1):72-76.
PMID: 31856472
PMC: 6951183.
DOI: 10.4103/ijo.IJO_406_19.
Active-fluidics-based torsional phacoemulsification in diabetic eyes: A prospective interventional study.
Khokhar S, Sen S, Dhull C
Indian J Ophthalmol. 2019; 67(5):619-624.
PMID: 31007221
PMC: 6498917.
DOI: 10.4103/ijo.IJO_1146_18.
Association of Diabetes With Central Corneal Thickness Among a Multiethnic Asian Population.
Luo X, Dai W, Chee M, Tao Y, Chua J, Tan N
JAMA Netw Open. 2019; 2(1):e186647.
PMID: 30646192
PMC: 6324536.
DOI: 10.1001/jamanetworkopen.2018.6647.
Proteomic analysis of corneal endothelial cell-descemet membrane tissues reveals influence of insulin dependence and disease severity in type 2 diabetes mellitus.
Skeie J, Aldrich B, Goldstein A, Schmidt G, Reed C, Greiner M
PLoS One. 2018; 13(3):e0192287.
PMID: 29529022
PMC: 5846724.
DOI: 10.1371/journal.pone.0192287.
Comparative Evaluation of Corneal Endothelium in Patients with Diabetes Undergoing Phacoemulsification.
Sahu P, Das G, Agrawal S, Kumar S
Middle East Afr J Ophthalmol. 2017; 24(2):74-80.
PMID: 28936050
PMC: 5598306.
DOI: 10.4103/meajo.MEAJO_242_15.
Unravelling the stromal-nerve interactions in the human diabetic cornea.
Priyadarsini S, Rowsey T, Ma J, Karamichos D
Exp Eye Res. 2017; 164:22-30.
PMID: 28827027
PMC: 6155456.
DOI: 10.1016/j.exer.2017.08.003.
Establishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal Diabetes.
Priyadarsini S, Sarker-Nag A, Rowsey T, Ma J, Karamichos D
PLoS One. 2016; 11(12):e0168845.
PMID: 28005998
PMC: 5179241.
DOI: 10.1371/journal.pone.0168845.